Home » Topics » BioWorld Science

BioWorld Science
RSS

Titan and Novartis to conduct further trials of iloperidone prior to submission

July 26, 2001

OSI-774 to be tested in combination therapy for NSCLC

July 26, 2001

Questcor's Emitasol receives approval in the Czech Republic and Poland

July 26, 2001

Enzon begins phase II trial of Prothecan

July 26, 2001

Promising results reported from Multikine study in HPV-induced cervical dysplasia

July 26, 2001

Phase I/II clinical trials of StreptAvax commence

July 26, 2001

Binding characteristics and effects on steroid synthesis of two new PBR ligands

July 26, 2001

EpiGenesis obtains license to Genta antisense patents

July 26, 2001

S. pneumoniae DNA vaccine encoding PPS4 peptide mimetic induces specific immune response in mice

July 26, 2001

Two compounds enter preclinical development at Serono

July 26, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Jiangsu Nhwa Pharmaceutical patents new κ-opioid receptor antagonists
BioWorld Science
Jiangsu Nhwa Pharmaceutical Co. Ltd. has disclosed κ-opioid receptor antagonists that are potentially useful for the treatment of neurological disorders.